Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 163 Breast Neoplasms 123 Lung Neoplasms 101 Carcinoma, Non-Small-Cell Lung 83 Glioblastoma 77 Brain Neoplasms 74 Neoplasm Metastasis 68 Glioma 68 Pancreatic Neoplasms 50 Neoplasms 45 Carcinoma, Renal Cell 45 Multiple Myeloma 44 Colorectal Neoplasms 43 Squamous Cell Carcinoma of Head and Neck 39 Lymphoma, Large B-Cell, Diffuse 39 Carcinoma, Hepatocellular 36 Ovarian Neoplasms 34 Melanoma 34 Lymphoma 34 Urinary Bladder Neoplasms 33 Astrocytoma 30 Sarcoma 26 Rectal Neoplasms 26 Uterine Cervical Neoplasms 24 Oropharyngeal Neoplasms 24 Lymphoma, Follicular 24 Central Nervous System Neoplasms 24 Lymphoma, Non-Hodgkin 23 Triple Negative Breast Neoplasms 22 Gliosarcoma 22

Interventions

Hyperthermic Intraperitoneal Chemotherapy 28 Paclitaxel 24 Cisplatin 23 Oxaliplatin 18 Cytoreduction Surgical Procedures 17 Carboplatin 17 Fluorouracil 14 Bevacizumab 10 Mitomycin 9 Leucovorin 9 Doxorubicin 9 Docetaxel 6 Gemcitabine 5 130-nm albumin-bound paclitaxel 5 Surgical Procedures, Operative 4 Neoadjuvant Therapy 4 Blood Specimen Collection 4 Albumin-Bound Paclitaxel 4 sodium thiosulfate 3 liposomal doxorubicin 3 catumaxomab 3 Taxes 3 Laparoscopy 3 Drug Therapy 3 Chemotherapy, Adjuvant 3 tremelimumab 2 relacorilant 2 pembrolizumab 2 olaparib 2 nintedanib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Peritoneal Neoplasms × Magnetic Resonance Spectroscopy × Clear all

NCT07001748 2026-05-15

STOPGAP II

Eastern Cooperative Oncology Group

Phase 2/3 Recruiting

Peritoneal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡